申请人:Zeneca Limited
公开号:US06124281A1
公开(公告)日:2000-09-26
The invention relates to azolobenzazepine derivatives of formula (I), wherein: X is O or S; R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are independently hydrogen, perfluorolower-alkyl, halogen, nitro or cyano; and C together with the carbon atoms to which it is attached forms a 5-membered aromatic heterocycle selected from the group consisting of a pyrazol and triazole, to pharmaceutical compositions containing them and to methods for the treatment of neurological disorders utilizing them. ##STR1##
这项发明涉及式(I)的氮杂苯并蒽啉衍生物,其中:X为O或S;R.sup.1、R.sup.2、R.sup.3和R.sup.4分别为氢、全氟较低烷基、卤素、硝基或氰基;C与其连接的碳原子一起形成从吡唑和三唑组成的5-成员芳香杂环,以及含有它们的药物组合物和利用它们治疗神经系统疾病的方法。